Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
- CAS No.
- 149839-65-6
- Chemical Name:
- Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
- Synonyms
- Etoposide EP impurity R (S configuration);Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(...;Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
- CBNumber:
- CB49812158
- Molecular Formula:
- C50H50O20
- Molecular Weight:
- 970.93
- MDL Number:
- MOL File:
- 149839-65-6.mol
Last updated:2022-12-21 16:56:50
Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]- Properties
Density | 1.58±0.1 g/cm3(Predicted) |
---|---|
pka | 9.94±0.40(Predicted) |
FDA UNII | SD2141W3YA |
Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]- Preparation Products And Raw materials
Raw materials
Preparation Products
Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]- Suppliers
Global( 2)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
TOSUN PHARM | 020-61855200 13326451905 | 2881290884@qq.com | China | 7524 | 58 |
Henan Vcommend Consultrading Co., Ltd. | 13393721940 | sales@vcommend.com | China | 9944 | 58 |
Supplier | Advantage |
---|---|
TOSUN PHARM | 58 |
Henan Vcommend Consultrading Co., Ltd. | 58 |
Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
Etoposide EP impurity R (S configuration)
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(...
149839-65-6